Cartesian Therapeutics (RNAC) Capital Expenditures (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Capital Expenditures of $272,000 for Q2 2026, down 89.5% from $2.6 million a year earlier but up 907.4% from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Capital Expenditures (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cartesian Therapeutics' Capital Expenditures came in at $2.08 million, down 80.3% year-over-year; for FY2025, it was $5.45 million, down 40.0% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of 46.3% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $9.09 million in FY2024, $206,000 in FY2023 (-82.8%), $1.2 million in FY2022 (+10.7%) and $1.09 million in FY2021 (+33.1%).
- Five-year quarterly Capital Expenditures spans a low of $12,000 in Q2 2023 and a high of $6.2 million in Q3 2024.
- Year over year, Capital Expenditures has now declined in each of the last four quarters, with an average decline of 25.7% over the last six quarters.
- The high point for year-over-year Capital Expenditures in five years was Q1 2024 (growth of 363.1%); the low point was Q1 2026 (a decline of 97.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $27,000 (Q1 2026), $492,000 (Q4 2025) and $1.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Cartesian Therapeutics | 216.57 Mn | 216.57 Mn | - | 272,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 272,000.00 |
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | 492,000.00 |
| Sep 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 705,000.00 |
| Sep 30, 2024 | 6.20 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 602,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Mar 31, 2023 | 130,000.00 |
| Dec 31, 2022 | 211,000.00 |
| Sep 30, 2022 | 436,000.00 |
| Jun 30, 2022 | 99,000.00 |
| Mar 31, 2022 | 455,000.00 |
| Dec 31, 2021 | 278,000.00 |
| Sep 30, 2021 | 164,000.00 |
| Jun 30, 2021 | 618,000.00 |
API Access
Cartesian Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();